Girard Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,664
| Closed | -$212K | – | 260 |
|
|
2024
Q1 | $212K | Sell |
2,664
-701
| -21% | -$53.5K | 0.02% | 255 |
|
|
2023
Q4 | $266K | Sell |
3,365
-877
| -21% | -$62.4K | 0.03% | 223 |
|
|
2023
Q3 | $296K | Sell |
4,242
-802
| -16% | -$56.8K | 0.03% | 204 |
|
|
2023
Q2 | $349K | Sell |
5,044
-2,762
| -35% | -$197K | 0.04% | 197 |
|
|
2023
Q1 | $580K | Sell |
7,806
-3,052
| -28% | -$256K | 0.06% | 168 |
|
|
2022
Q4 | $1.01M | Sell |
10,858
-496
| -4% | -$47.9K | 0.11% | 149 |
|
|
2022
Q3 | $1.08M | Sell |
11,354
-24,411
| -68% | -$2.42M | 0.14% | 122 |
|
|
2022
Q2 | $3.31M | Buy |
35,765
+446
| +1% | +$43.5K | 0.42% | 68 |
|
|
2022
Q1 | $3.57M | Buy |
35,319
+18,247
| +107% | +$1.92M | 0.39% | 72 |
|
|
2021
Q4 | $1.76M | Buy |
17,072
+2,001
| +13% | +$185K | 0.19% | 106 |
|
|
2021
Q3 | $1.28M | Buy |
15,071
+3,660
| +32% | +$307K | 0.16% | 112 |
|
|
2021
Q2 | $952K | Sell |
11,411
-143
| -1% | -$11.7K | 0.12% | 123 |
|
|
2021
Q1 | $869K | Sell |
11,554
-3,065
| -21% | -$223K | 0.13% | 119 |
|
|
2020
Q4 | $998K | Sell |
14,619
-5,204
| -26% | -$338K | 0.15% | 107 |
|
|
2020
Q3 | $1.16M | Sell |
19,823
-28,756
| -59% | -$1.79M | 0.19% | 102 |
|
|
2020
Q2 | $3.16M | Sell |
48,579
-6,886
| -12% | -$434K | 0.57% | 51 |
|
|
2020
Q1 | $3.29M | Buy |
55,465
+7,485
| +16% | +$500K | 0.66% | 45 |
|
|
2019
Q4 | $3.56M | Buy |
47,980
+1,499
| +3% | +$105K | 0.59% | 53 |
|
|
2019
Q3 | $2.93M | Sell |
46,481
-5,448
| -10% | -$323K | 0.55% | 59 |
|
|
2019
Q2 | $2.83M | Buy |
51,929
+7,012
| +16% | +$378K | 0.5% | 65 |
|
|
2019
Q1 | $2.42M | Buy |
44,917
+9,208
| +26% | +$568K | 0.45% | 68 |
|
|
2018
Q4 | $2.34M | Sell |
35,709
-2,963
| -8% | -$221K | 0.49% | 65 |
|
|
2018
Q3 | $3.04M | Sell |
38,672
-1,694
| -4% | -$121K | 0.54% | 56 |
|
|
2018
Q2 | $2.6M | Buy |
40,366
+3,582
| +10% | +$236K | 0.49% | 61 |
|
|
2018
Q1 | $2.29M | Sell |
36,784
-4,862
| -12% | -$349K | 0.54% | 55 |
|
|
2017
Q4 | $3.02M | Sell |
41,646
-25,044
| -38% | -$1.82M | 0.58% | 56 |
|
|
2017
Q3 | $5.42M | Buy |
66,690
+1,775
| +3% | +$140K | 1.12% | 28 |
|
|
2017
Q2 | $5.22M | Buy |
64,915
+4,893
| +8% | +$386K | 1.13% | 24 |
|
|
2017
Q1 | $4.71M | Buy |
60,022
+15,361
| +34% | +$1.23M | 1.14% | 23 |
|
|
2016
Q4 | $3.52M | Sell |
44,661
-1,419
| -3% | -$115K | 1.02% | 31 |
|
|
2016
Q3 | $4.1M | Buy |
46,080
+10,902
| +31% | +$1.03M | 1.37% | 19 |
|
|
2016
Q2 | $3.37M | Buy |
35,178
+10,766
| +44% | +$1.07M | 1.28% | 17 |
|
|
2016
Q1 | $2.53M | Buy |
24,412
+5,144
| +27% | +$500K | 1.11% | 26 |
|
|
2015
Q4 | $1.88M | Buy |
19,268
+7,396
| +62% | +$724K | 0.91% | 39 |
|
|
2015
Q3 | $1.15M | Buy |
+11,872
| New | +$1.25M | 0.65% | 54 |
|
Other funds holding CVS
Girard Partners's CVS Position: Q2 2024 in Review
Girard Partners sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,664 shares — an estimated $212K sold.
Girard Partners first reported a position in CVS in Q3 2015 and held it in 35 quarters. The position peaked at $5.42M in Q3 2017. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Girard Partners reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Girard Partners sold 2,664 CVS Health shares in Q2 2024, an estimated $212K.
- Girard Partners first reported a position in CVS Health in Q3 2015 and held it in 35 quarters.
- Girard Partners's CVS Health position peaked at $5.42M in Q3 2017.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.